MARKSANSMarksans Pharma Limited

Latest close

299.9

+1.13%

Price

Price history

24/09/2026 to 27/10/2026

O 300.25 H 303.10 L 294.80

342.80286.7524/09/202627/10/2026

Performance

Day low

294.80

Day high

303.10

52 week low

156.00

52 week high

350.75

Open price

300.25

Previous close

296.55

Volume

60,828

1M

-9.24%

1Y

+68.63%

30D avg vol

1.1L

Fundamentals

Jun-26 · 30/06/2026

SectorBroad business classification for this issuer.Healthcare
IndustryNarrower business classification inside the sector.Equity
52W HighHighest traded price over the latest 52-week window.350.75
52W LowLowest traded price over the latest 52-week window.156.00
Market capCompany value from the latest fundamentals row, shown in crore or lakh-crore.₹13,599.44 Cr
P/EPrice-to-earnings ratio: market price divided by earnings per share.26.09
P/BPrice-to-book ratio: market price divided by book value per share.4.50
EPSEarnings per share from the latest fundamentals.₹3.47
Div yieldDividend yield: annual dividend relative to market price.0.30%
RevenueRevenue reported in the latest fundamentals period.₹840.80 Cr
PATProfit after tax reported in the latest fundamentals period.₹159.41 Cr

Financials

Financial performance

RevenuePAT
Revenue growth+35.6%
Profit growth+173.9%

Membership

Index exposure

No current index membership found for this stock.

Corporate actions

Dividends, splits, bonuses, buybacks

Ex-dateActionDetail
20/08/2026Dividend - Re 0.90 Per ShareDividend - Re 0.90 Per Share
01/08/2025Dividend - Re 0.80 Per ShareDividend - Re 0.80 Per Share

Bulk deals

Block trades reported to exchanges

DateSideClientQtyAvg price
12/08/2026SELLMICROCURVES TRADING PRIVATE LIMITED43,49,697313.40
12/08/2026BUYMICROCURVES TRADING PRIVATE LIMITED43,49,697313.24

Insider trades

Disclosures by promoters and officers

DateSidePersonQtyCategory
11/09/2026BUYMerrill Jean Saldanha63,273Directors Immediate Relative
11/09/2026BUYMarise Ann Saldanha20,000Directors Immediate Relative
11/09/2026BUYSchenelle Megan Saldanha1,45,000Directors Immediate Relative
11/09/2026SELLSandra Saldanha2,28,273Director

Other filings

Misc disclosures

DateTypeTitle
12/08/2026ResultsJun-26 results
26/05/2026ResultsFY25-26 results
26/05/2026ResultsMar-26 results
05/02/2026ResultsDec-25 results
13/11/2025ResultsSep-25 results